Impact of Anemia Management with EPO on Psychologic Distress in Cancer Patients: Results of a Multicenter Patient Survey
Salvatore Del Prete(Federico II University Hospital), Raffaele Addeo(George Moore Community Clinic), Saverio Cinieri(Ospedale A. Perrino), Vincenzo Montesarchio(CTO Hospital), Gabriella Misso(University of Campania "Luigi Vanvitelli"), Gianfranco Filippelli(Presidio Ospedaliero), Roberto Mabilia(Ospedale Sant'Anna), Enrico Barbato(Azienda Ospedaliera S.Giuseppe Moscati), Riccardo Tonachella, Agata Pisano(University of Campania "Luigi Vanvitelli"), Clementina Savastano, Antonio Febbraro(Fatebenefratelli Hospital), Michele Caraglia(University of Campania "Luigi Vanvitelli"), Bruno Vincenzi(Campus Bio Medico University Hospital), Gregorio Cennamo(Nuovo Ospedale San Giovanni di Dio), Carmine Pizza, Luigi Manzione, Luigi Leo, G. R. Pistolese(Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona), Vito Lorusso(Ospedale Vito Fazzi), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Salvatore Palazzo(Azienda Ospedaliera di Cosenza), Luigi Maiorino(Medical Center Hospital)
Cited by 2
Related Papers
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
|Journal of Clinical Oncology|2012|234
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|Annals of Oncology|2009|205
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
|Journal of Clinical Oncology|2017|186
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
|Cancer Discovery|2020|183
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
|The Journal of Clinical Endocrinology & Metabolism|2019|180